EastGate Acquisitions Receives Research Grant From Ontario Brain Institute

SALT LAKE CITY and TORONTO, June 25, 2014 /PRNewswire via COMTEX/ EastGate Acquisitions Corporation (OTCBB:ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules announces today that it has received a research grant from the Ontario Brain Institute for its Lorazepam Spray development. The grant was issued for the purpose to study the administration of a transmucosal Lorazepam Spray for the treatment epileptic seizures in the outpatient settings. As previously announced the company has entered into a collaboration with a leading neurologist, Dr. Peter Carlen, at the Toronto Western Hospital who will serve as a principal investigator on this trial. The grant represents a continued funding of a two-year budget as submitted to the Ontario Brain Institute under the Epilepsy Discovery Project 2013 Continuing Research Study Proposal. The intraoral Lo
http://bit.ly/1rypWRu